There are indications of anti-tumor efficacy, however, with RRV encoding secreted single chain variable fragment (scFv) against PD-L1 (RRV-scFc-PDL1) in a murine model of orthotopic glioma [94]. The gene discussed is CD274; the disease is central nervous system cancer.